New potential of ACE inhibitors in clinical practice
The paper reviews the results of the studies demonstrating new potential of ACE inhibitors. The traditional clinical niche for ACE inhibitor therapy (arterial hypertension, heart failure, diabetic nephropathy) has been extended recently. Substantial vasoprotective effect of these medications has an...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2010-10-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2129 |
| _version_ | 1797882631519469568 |
|---|---|
| author | D. V. Nebieridze A. S. Safaryan |
| author_facet | D. V. Nebieridze A. S. Safaryan |
| author_sort | D. V. Nebieridze |
| collection | DOAJ |
| description | The paper reviews the results of the studies demonstrating new potential of ACE inhibitors. The traditional clinical niche for ACE inhibitor therapy (arterial hypertension, heart failure, diabetic nephropathy) has been extended recently. Substantial vasoprotective effect of these medications has an important role in decelerating progression of atherosclerotic cardiovascular pathology. In addition, a differential assessment of protective effects, together with prognosis improvement among high-risk patients, is presented for various ACE inhibitors. |
| first_indexed | 2024-04-10T03:38:54Z |
| format | Article |
| id | doaj.art-e40cea419f844efbba5869a8d7470b23 |
| institution | Directory Open Access Journal |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| last_indexed | 2024-04-10T03:38:54Z |
| publishDate | 2010-10-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj.art-e40cea419f844efbba5869a8d7470b232023-03-13T07:23:18Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252010-10-019591941838New potential of ACE inhibitors in clinical practiceD. V. Nebieridze0A. S. Safaryan1Государственный научно-исследовательский центр профилактической медицины “Росмедтехнологии”. МоскваГосударственный научно-исследовательский центр профилактической медицины “Росмедтехнологии”. МоскваThe paper reviews the results of the studies demonstrating new potential of ACE inhibitors. The traditional clinical niche for ACE inhibitor therapy (arterial hypertension, heart failure, diabetic nephropathy) has been extended recently. Substantial vasoprotective effect of these medications has an important role in decelerating progression of atherosclerotic cardiovascular pathology. In addition, a differential assessment of protective effects, together with prognosis improvement among high-risk patients, is presented for various ACE inhibitors.https://cardiovascular.elpub.ru/jour/article/view/2129ингибиторы ангиотензин-превращающего ферментазаболевания атеросклеротического генезаулучшение прогнозакласс-эффект ингибиторов ангиотензин-превращающего фермента |
| spellingShingle | D. V. Nebieridze A. S. Safaryan New potential of ACE inhibitors in clinical practice Кардиоваскулярная терапия и профилактика ингибиторы ангиотензин-превращающего фермента заболевания атеросклеротического генеза улучшение прогноза класс-эффект ингибиторов ангиотензин-превращающего фермента |
| title | New potential of ACE inhibitors in clinical practice |
| title_full | New potential of ACE inhibitors in clinical practice |
| title_fullStr | New potential of ACE inhibitors in clinical practice |
| title_full_unstemmed | New potential of ACE inhibitors in clinical practice |
| title_short | New potential of ACE inhibitors in clinical practice |
| title_sort | new potential of ace inhibitors in clinical practice |
| topic | ингибиторы ангиотензин-превращающего фермента заболевания атеросклеротического генеза улучшение прогноза класс-эффект ингибиторов ангиотензин-превращающего фермента |
| url | https://cardiovascular.elpub.ru/jour/article/view/2129 |
| work_keys_str_mv | AT dvnebieridze newpotentialofaceinhibitorsinclinicalpractice AT assafaryan newpotentialofaceinhibitorsinclinicalpractice |